Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.

Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the...

Full description

Bibliographic Details
Main Authors: Jing Zhang, Fitz Gerald S Silao, Ursela G Bigol, Alice Alma C Bungay, Marilou G Nicolas, Joseph Heitman, Ying-Lien Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3432075?pdf=render
id doaj-61147729c117437baca63a78ae53f2f1
record_format Article
spelling doaj-61147729c117437baca63a78ae53f2f12020-11-25T00:23:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4419210.1371/journal.pone.0044192Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.Jing ZhangFitz Gerald S SilaoUrsela G BigolAlice Alma C BungayMarilou G NicolasJoseph HeitmanYing-Lien ChenCandida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37°C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.http://europepmc.org/articles/PMC3432075?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jing Zhang
Fitz Gerald S Silao
Ursela G Bigol
Alice Alma C Bungay
Marilou G Nicolas
Joseph Heitman
Ying-Lien Chen
spellingShingle Jing Zhang
Fitz Gerald S Silao
Ursela G Bigol
Alice Alma C Bungay
Marilou G Nicolas
Joseph Heitman
Ying-Lien Chen
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
PLoS ONE
author_facet Jing Zhang
Fitz Gerald S Silao
Ursela G Bigol
Alice Alma C Bungay
Marilou G Nicolas
Joseph Heitman
Ying-Lien Chen
author_sort Jing Zhang
title Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
title_short Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
title_full Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
title_fullStr Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
title_full_unstemmed Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
title_sort calcineurin is required for pseudohyphal growth, virulence, and drug resistance in candida lusitaniae.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37°C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.
url http://europepmc.org/articles/PMC3432075?pdf=render
work_keys_str_mv AT jingzhang calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT fitzgeraldssilao calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT urselagbigol calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT alicealmacbungay calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT marilougnicolas calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT josephheitman calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
AT yinglienchen calcineurinisrequiredforpseudohyphalgrowthvirulenceanddrugresistanceincandidalusitaniae
_version_ 1725355874301509632